Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-LDL-syndrome”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Early research (Phase 1)UnknownNCT05839236
What this trial is testing

COVID-19 Vaccination Detoxification in LDL-C

Who this might be right for
COVID-19 Stress SyndromeCOVID-19 Vaccine Adverse ReactionCOVID-19-Associated Thromboembolism+3 more
Yang I. Pachankis 1
Not applicableStudy completedNCT05844566
What this trial is testing

OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

Who this might be right for
Acute Coronary SyndromeMyocardial Infarction
Imperial College London 1,139
Not applicableStudy completedNCT00932087
What this trial is testing

Characterization of Low Density Lipoprotein and Mechanism of the Pro Aggregant Effect Through Oxidant Stress and Lipid Exchange

Who this might be right for
DiabetesMetabolic Syndrome
Hospices Civils de Lyon 48
Large-scale testing (Phase 3)Study completedNCT02833844
What this trial is testing

Safety, Tolerability and Efficacy on Low Density Lipoprotein Cholesterol (LDL-C) of Evolocumab in Participants With Human Immunodeficiency Virus (HIV) and Hyperlipidemia/Mixed Dyslipidemia

Who this might be right for
Subjects With Hyperlipidemia, Dyslipidemia and HIV Infection
Amgen 467
Not applicableUnknownNCT05218005
What this trial is testing

Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia

Who this might be right for
Familial HypercholesterolemiaFamilial Hypercholesterolemia Due to Genetic Defect of Apolipoprotein BFamilial Hypercholesterolemia Due to Heterozygous LDL Receptor Mutation+5 more
University of British Columbia 250
Not applicableStudy completedNCT01114763
What this trial is testing

Hämeenlinna Metabolic Syndrome Research Program: Oxidized LDL and Arterial Elasticity in Metabolic Syndrome and Controls (HMS-01)

Who this might be right for
Metabolic Syndrome
Kanta-Häme Central Hospital 80
Not applicableUnknownNCT05043740
What this trial is testing

PCSK9 Inhibitor on ACS Patients With Multivessel Disease and Relatively Low LDL-C Level in Chinese Population

Who this might be right for
Acute Coronary Syndrome
Second Xiangya Hospital of Central South University 1,360
Large-scale testing (Phase 3)Study completedNCT01562080
What this trial is testing

Combined Effects of Bioactive Compounds in Lipid Profile

Who this might be right for
HyperlipidemiaLow-density-lipoprotein-typeElevated Triglycerides
Rottapharm Spain 118
Not applicableStudy completedNCT03678714
What this trial is testing

Effect of Exercise on Cardiometabolic Profile in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Sheffield Hallam University 37
Testing effectiveness (Phase 2)Study completedNCT00529542
What this trial is testing

A Trial of Lipitor (Atorvastatin) for the Treatment of Polycystic Ovary Syndrome (PCOS) in Women With Elevated Low-density Lipoprotein (LDL) Cholesterol

Who this might be right for
Polycystic Ovary Syndrome
Milton S. Hershey Medical Center 20
Not applicableNot Yet RecruitingNCT07462871
What this trial is testing

Comparative Effects of Carnivore and Mediterranean-style Diets on LDL Aggregation and Cardiometabolic Health

Who this might be right for
Atherosclerosis Cardiovascular DiseaseMetabolic SyndromeDyslipidaemia
Liverpool John Moores University 30
Not applicableStudy completedNCT03527277
What this trial is testing

Orange Juice And Sugar Intervention Study

Who this might be right for
Cardiovascular Risk FactorType2 Diabetes MellitusInsulin Sensitivity+1 more
University of California, Davis 56
Large-scale testing (Phase 3)Study completedNCT00204412
What this trial is testing

Exercise and Flax-Based Nutritional Supplementation for Lowering Cholesterol

Who this might be right for
Metabolic SyndromeOsteoporosis
University of Saskatchewan 100
Post-approval studies (Phase 4)Study completedNCT00405171
What this trial is testing

Efavirenz to Nevirapine Switch and Low-Density Lipoprotein (LDL)-Dyslipidemia

Who this might be right for
HIV InfectionsHypercholesterolemiaAntiretroviral Therapy
University Hospital, Caen 40
Not applicableStudy completedNCT06163443
What this trial is testing

Evaluating the Impact of B Vitamin Supplementation (Soloways™) on Homocysteine and LDL-C Levels in Patients With MTHFR, MTR, and MTRR Polymorphisms.

Who this might be right for
HyperhomocysteinemiaHyperlipoproteinemias
S.LAB (SOLOWAYS) 54
Not applicableStudy completedNCT00485121
What this trial is testing

Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis

Who this might be right for
Metabolic SyndromeObesityCoronary Artery Disease
Canadian Collaborative Research Network 50
Not applicableStudy completedNCT00805207
What this trial is testing

Sex Steroids, Sleep, and Metabolic Dysfunction in Women

Who this might be right for
Polycystic Ovary Syndrome (PCOS)Obstructive Sleep ApneaObesity
Washington University School of Medicine 61
Post-approval studies (Phase 4)UnknownNCT02077257
What this trial is testing

LDL-C Lowering Efficacy and Safety of Rosuvastatin 20 mg/Day to10 mg/Day in Chinese ACS(Acute Coronary Syndrome) Patients

Who this might be right for
Acute Coronary Syndrome
Committee of Cardio-Cerebral-Vascular Diseases of GSC 1,060
Not applicableStudy completedNCT03528031
What this trial is testing

Habitual Diet and Avocado Trial

Who this might be right for
Intra-abdominal FatMetabolic SyndromeHigh Cholesterol+11 more
Wake Forest University Health Sciences 1,008
Testing effectiveness (Phase 2)Ended earlyNCT03960541
What this trial is testing

Efprezimod Alfa (CD24Fc, MK-7110) Administration to Decrease Low-Density Lipoprotein (LDL) and Inflammation in Human Immunodeficiency Virus (HIV) Patients (CALIBER) (MK-7110-003)

Who this might be right for
HIV InfectionsDyslipidemias
Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 8
Load More Results